Genetic studies in the sleep disorder narcolepsy

Genome Research

Volumn 8, Issue 5, 1998, Pages 427-434

  Kadotani, Hiroshi ^a   Faraco, Juliette ^a   Mignot, Emmanuel ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNE DISEASE; AUTOSOMAL RECESSIVE INHERITANCE; CIRCADIAN RHYTHM; GENE ISOLATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; HUMAN CELL; MARKER GENE; MOLECULAR CLONING; NARCOLEPSY; NEUROLOGIC DISEASE; NONHUMAN; PENETRANCE; PRIORITY JOURNAL; PSEUDOGENE; REM SLEEP; REVIEW; SLEEP DISORDER; SOMNOLENCE;

ANIMALIA;

EID: 0031861061     PISSN: 10889051     EISSN: None     Source Type: Journal    
DOI: 10.1101/gr.8.5.427     Document Type: Review

References (63)

1. Albrecht, U., Z.S. Sun, G. Eichele, and C.C. Lee. 1997. A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light. Cell 91: 1055-1064.
2. Aldrich, M.S. 1991. The neurobiology of narcolepsy. Trends Neurosci. 14: 235-239.
3. _. 1992. Narcolepsy. Neurology (Suppl. 6) 42: 34-43.
4. Baker, T.L., A.S. Foutz, V. McNerney, M.M. Mitler, and W.C. Dement. 1982. Canine model of narcolepsy: Genetic and developmental determinants. Exp. Neurol. 75: 729-742.
5. Bassetti, C. and M.S. Aldrich. 1996. Narcolepsy. Neurol. Clin. 14: 545-571.
6. Begovich, A.B., G.R. McClure, V.C. Suraj, R.C. Helmuth, N. Fildes, T.L. Bugawan, H.A. Erlich, and W. Klitz. 1992. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J. Immunol. 148: 249-258.
7. Billiard, M., J. Seignalet, A. Besset, and J. Cadilhac. 1986. HLA-DR2 and narcolepsy. Sleep 9: 149-152.
8. Broughton, R., Q. Ghanem, Y. Hishikawa, Y. Sugita, S. Nevsimalova, and B. Roth. 1981. Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls. Can. J. Neurol. Sci. 8: 299-304.
9. Broughton, R., V. Valley, M. Aguirre, J. Roberts, W. Suwalski, and W. Dunham. 1986. Excessive daytime sleepiness and the pathophysiology of narcolepsy-cataplexy: A laboratory perspective. Sleep 9: 205-215.
10. Carlander, B., J.F. Eliaou, and M. Billiard. 1993. Autoimmune hypothesis in narcolepsy. Neurophysiol. Clin. 23: 15-22.
11. Charron, D. 1990. Molecular basis of human leukocyte antigen class II disease associations. Adv. Immunol. 48: 107-159.
12. Dean, R.R., T.S. Kilduff, W.C. Dement, F.C. Grumet. 1989. Narcolepsy without unique MHC class II antigen association: Studies in the canine model. Hum. Immunol. 25: 27-35.
13. Dunlap, J.C. 1996. Genetic and molecular analysis of circadian rhythms. Annu. Rev. Genet. 30: 579-601.
14. Ellis, M.C., A.H. Hetisimer, D.A. Ruddy, S.L. Hansen, G.S. Kronmal, E. McClelland, L. Quintana, D.T. Drayna, M.S. Aldrich, and E. Mignot. 1997. HLA class II haplotype and sequence analysis support a role for DQ in narcolepsy. Immunogenetics 46: 410-417.
15. Esser, C. and A. Radbruch. 1990. Immunoglobulin class switching: Molecular and cellular analysis. Annu. Rev. Immunol. 8: 717-735.
16. Faraco, J., X. Lin, R. Li, L. Hinton, L. Lin, and E. Mignot. 1998. Genetic studies in narcolepsy, a disorder of REM sleep. J. Hered. (in press).
17. Fredrikson, S., B. Carlander, M. Billiard, and H. Link. 1990. CSF immune variables in patients with narcolepsy. Acta. Neurol. Scand. 81: 253-254.
18. Guilleminault, C., E. Mignot, F.C. Grumet. 1989. Familial patterns of narcolepsy. Lancet 2: 1376-1379.
19. Hall, J.C. 1995. Tripping along the trail to the molecular mechanisms of biological clocks. Trends. Neurosci. 18: 230-240.
20. Honda, Y. 1988. Clinical features of narcolepsy: Japanese experiences. In HLA in narcolepsy (ed. Y. Honda and T. Juji), pp. 24-57. Springer-Verlag, Berlin, Germany.
21. Honda, Y., Y. Doi, T. Juji, and M. Satake. 1984. Narcolepsy and HLA: Positive DR2 as a prerequisite for the development of narcolepsy. Folia. Psychiatr. Neurol. Jpn. 38: 360.
22. Hublin, C., J. Kaprio, M. Partinen, M. Koskenvuo, K. Heikkila, S. Koskimies, and C. Guilleminault. 1994. The prevalence of narcolepsy: An epidemiological study of the Finnish twin cohort. Ann. Neurol. 35: 709-716.
23. Juji, T., M. Satake, Y. Honda, and Y. Doi. 1984. HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. Tissue Antigens 24: 316-319.
24. King, D.P., Y. Zhao, A.M. Sangoram, L.D. Wilsbacher, M. Tanaka, M.P. Antoch, T.D.L. Steeves, M.H. Vitaterna, J.M. Kornhauser, P.L. Lowrey, F.W. Turek, and J.S. Takahashi. 1997. Positional cloning of the mouse circadian Clock gene. Cell 89: 641-653.
25. Knecht, C.D., J.E. Oliver, R. Redding, R. Selcer, and G. Johnson. 1973. Narcolepsy in a dog and a cat. J. Am. Vet. Med. Assoc. 162: 1052-1053.
26. Krueger, J.M. and M.L. Karnovsky. 1995. Sleep as a neuroimmune phenomenon: A brief historical perspective. Adv. Neuroimmunol. 5: 5-12.
27. Langdon, N., K.I. Welsh, M. van Dam, R.W. Vaughan, and D. Parkes. 1984. Genetic markers in narcolepsy. Lancet 2: 1178-1180.
28. Lin, L., L. Jin, A. Kimura, M. Carrington, and E. Mignot. 1997. DQ microsatellite association studies in three ethnic groups. Tissue Antigens 50: 507-520.
29. Lock, C.B., A.K.L. So, K.I. Welsh, J.D. Parkes, and J. Trowsdale. 1988. MHC class II sequences of an HLA-DR2 narcoleptic. Immunogenetics 27: 449-455.
30. Matsuki. K., Y. Honda, M. Satake, and T. Juji. 1988a. HLA in narcolepsy in Japan. In HLA in narcolepsy (ed. Y. Honda and T. Juji), pp. 58-75. Springer-Verlag, Berlin, Germany.
31. Matsuki. K., T. Juji, and Y. Honda. 1988b. Immunological features of narcolepsy in Japan. In HLA in narcolepsy (ed. Y. Honda and T. Juji), pp. 150-157. Springer-Verlag, Berlin, Germany.
32. Matsuki, K., F.C. Grumet, X. Lin, M. Gelb, C. Guilleminault, W.C. Dement, and E. Mignot. 1992. DQ (rather than DR) gene marks susceptibility to narcolepsy. Lancet 339: 1052.
33. Mehler, M.F. and J.A. Kessler. 1997. Hematolymphopoietic and inflammatory cytokines in neural development. Trends Neurosci 20: 357-365.
34. Mignot, E. 1996. Perspectives in narcolepsy research and therapy. Curr. Opin. Pulm. Med. 2: 482-487.
35. _. 1998. Genetic and familial aspects of narcolepsy. Neurology (Suppl. 1) 50: S16-S22.
36. Mignot, E., C. Wang, C. Rattazzi, C. Gaiser, M. Lovett, C. Guilleminault, W.C. Dement, and F.C. Grumet. 1991. Genetic linkage of autosomal recessive canine narcolepsy with a μ immunoglobulin heavy-chain switch-like segment. Proc. Natl. Acad. Sci. 88: 3475-3478.
37. Mignot, E., X. Lin, J. Kalil, C. George, S. Singh, M. Billiard, J. Montplaisir, J. Arrigoni, C. Guilleminault, W.C. Dement, and F.C. Grumet. 1992. DQB1-0602 (DQw1) is not present in most nonDR2 Caucasian narcoleptics. Sleep 15: 415-422.
38. Mignot, E., S. Nishino, L.H. Sharp, J. Arrigoni, J.M. Siegel, M.S. Reid, D.M. Edgar, R.D. Ciaranello, and W.C. Dement. 1993. Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: Induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholinergic systems. J. Neurosci. 13: 1057-1064.
39. Mignot, E., X. Lin, J. Arrigoni, C. Macaubas, F. Olive, J. Hallmayer, P. Underhill, C. Guilleminault, W.C. Dement, and F.C. Grumet. 1994. DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. Sleep 17: S60-S67.
40. Mignot, E., M. Tafti, W.C. Dement, and F.C. Grumet. 1995a. Narcolepsy and immunity. Adv. Neuroimmunol. 5: 23-37.
41. Mignot, E., E. Lister, R. Burnett, H.J. Deeg, S. Nishino, W.C. Dement, and R. Storb. 1995b. Bone marrow transplantation studies in canine narcolepsy. Sleep Res. 24: 297.
42. Mignot, E., J. Meehan, F.C. Grumet, J. Hallmeyer, C. Guilleminault, P.E. Hesla, S. Nevsimalova, G. Mayer, and W.C. Dement. 1996. HLA class II and narcolepsy in thirty-three multiplex families. Sleep Res. 25: 303.
43. Mignot, E., A. Kimura, A. Lattermann, X. Lin, S. Yasunaga, G . Mueller-Eckhardt, C. Rattazzi, L. Lin, C. Guilleminault, F.C. Grumet, G. Mayer, W.C. Dement, and P. Underhill. 1997a. Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy. Tissue Antigens 49: 329-341.
44. Mignot, E., R. Hayduk, J. Black, F.C. Grumet, and C. Guilleminault. 1997b. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 20: 1012-1020.
45. Miller, M.M., B.G. Boysen, L. Campbell, and W.C. Dement. 1974. Narcolepsy-cataplexy in a female dog. Exp. Neurol. 45: 332-340.
46. Morganti-Kossmann, M.C., T. Kossmann, and S.M. Wahl. 1992. Cytokines and neuropathology. Trends Pharmacol. Sci. 13: 286-291.
47. Arnason. 1987. HLA antigens in narcolepsy. Neurology 37: 1858-1860.
48. Nishino, S. and E. Mignot. 1997. Pharmacological aspects of human and canine narcolepsy. Prog. Neurobiol. 52: 27-78.
49. _. 1998. Neurobiology of narcolepsy. Neuroscientist 4(2): 133-143.
50. Parkes, J.D., N. Langdon, and C. Lock. 1986. Narcolepsy and immunity. Br. Med. J. 292: 359-360.
51. Pelin, Z., C. Guilleminault, N. Risch, F.C. Grumet, U.S. Modafinil in Narcolepsy Multicenter Study Group, and E. Mignot. 1998. HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. Tissue Antigens 51: 96-100.
52. Rogers, A.E., J. Meehan, C. Guilleminault, F.C. Grumet, and E. Mignot. 1997. HLA DR15 (DR2) and DQB1*0602 typing studies in 188 narcoleptic patients with cataplexy. Neurology 48: 1550-1556.
53. Rosbash, M., R. Allada, M. Dembinska, W.Q. Guo, M. Le, S. Marrus, Z. Qian, J. Rutila, J. Yaglom, and H. Zeng. 1996. A Drosophila circadian clock. Cold Spring Harbor Symp. Quant. Biol. 61: 265-278.
54. Roth, B. 1980. Narcolepsy and hypersomnia. Karger, Basel, Switzerland.
55. Rubin, R.L., R.M. Hajdukovich, and M.M. Mitler. 1988. HLA-DR2 association with excessive somnolence in narcolepsy does not generalize to sleep apnea and is not accompanied by systemic autoimmune abnormalities. Clin. Immunol. Immunopathol. 49: 149-158.
56. Shearman, L.P., M.J. Zylka, D.R. Weaver, L.F. Kolakowski, Jr., and S.M. Reppert. 1997. Two period homologs: Circadian expression and photic regulation in the suprachiasmatic nuclei. Neuron 19: 1261-1269.
57. Shigeyoshi, Y., K. Taguchi, S. Yamamoto, S. Takekida, L. Yan, H. Tei, T. Moriya, S. Shibata, J.J. Loros, J.C. Dunlap, and H. Okamura. 1997. Light-induced resetting of a mammalian circadian clock is associated with rapid induction of the mPer1 transcript. Cell 91: 1043-1053.
58. Tafti, M., S. Nishino, M.S. Aldrich, W. Liao, W.C. Dement, and E. Mignot. 1996. Major histocompatibility class II molecules in the CNS: Increased microglial expression at the onset of narcolepsy in a canine model. J. Neurosci. 16: 4588-4595.
59. Tei, H., H. Okamura, Y. Shigeyoshi, C. Fukuhara, R. Ozawa, M. Hirose, and Y. Sakaki. 1997. Circadian oscillation of a mammalian homologue of the Drosophila period gene. Nature 389: 512-516.
60. Uryu, N., M. Maeda, Y. Nagata, K. Matsuki, T. Juji, Y. Honda, J. Kawai, A. Ando, K. Tsuji, and H. Inoko. 1989. No difference in the nucleotide sequence of the DQβ β1 domain between narcoleptic and healthy individuals with DR2,Dw2. Hum. Immunol. 24: 175-181.
61. van Bekkum, D.W. 1993. BMT in experimental autoimmune diseases. Bone Marrow Transplant 11: 183-187.
62. Wilder, R.L. 1995. Neuroendocrine-immune system interactions and autoimmunity. Annu. Rev. Immunol. 13: 307-338.
63. Young, M.W., K. Wager-Smith, L. Vosshall, L. Saez, and M.P. Myers. 1996. Molecular anatomy of a light-sensitive circadian pacemaker in Drosophila. Cold Spring Harbor Symp. Quant. Biol. 61: 279-284.